Skip to main content
Erschienen in: Pathology & Oncology Research 2/2011

01.06.2011 | Research

Involvement of c-Ski Oncoprotein in Carcinogenesis of Cholangiocacinoma Induced by Opisthorchis viverrini and N-nitrosodimethylamine

verfasst von: Thidarut Boonmars, Zhiliang Wu, Sirintip Boonjaruspinyo, Anucha Puapairoj, Butsara Kaewsamut, Isao Nagano, Somchai Pinlaor, Puangrat Yongvanit, Orasa Wonkchalee, Amornrat Juasook, Pakkayanee Sudsarn, Tuanchai Srisawangwong

Erschienen in: Pathology & Oncology Research | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Opisthorchiasis is the major public health problem in the endemic areas of Thailand and Laos because Opisthorchis viverrini infection causes serious hepatobiliary diseases including CCA. The molecular mechanism of the CCA carcinogenesis induced by the infection remains obscure. To reveal the potential genes and signaling pathways to involve in the carcinogenesis, the present study investigated the expression of c-Ski, an oncogene, and two TGF-β signaling pathway relative genes, TGF-β and Smad4, during the development of CCA induced by O. viverrini infection in hamster model, and in human opisthorchiasis associated CCA. The results showed that the expression of c-Ski gene was greatly up-regulated during the carcinogenesis of CCA in hamster model. The overexpression of c-Ski was confirmed by immunohistological staining result which showed the increased expression of c-Ski protein in cytoplasm of the epithelial lining of hepatic bile ducts. Moreover, the immunohistological staining of the specimens of human opisthorchiasis associated CCA revealed the up-regulated expression of c-Ski and Smad4 proteins in the cytoplasm of the epithelial lining of hepatic bile ducts and stomal fibrosis respectively. The expression of TGF-β and Smad4 were up-regulated, which expression kinetics was time-dependent of CCA development. These results suggest that c-Ski is likely involved in the carcinogenesis of CCA induced by O. viverrini infection through regulating TGF-β signaling pathway.
Literatur
1.
Zurück zum Zitat IARC (1994) Infection with liver flukes (Opisthorchis viverrini, Opisthorchis felineus and Clonorchis sinensis). IARC Monogr Eval Carcinog Risk Chem Hum 61:121–175 IARC (1994) Infection with liver flukes (Opisthorchis viverrini, Opisthorchis felineus and Clonorchis sinensis). IARC Monogr Eval Carcinog Risk Chem Hum 61:121–175
2.
Zurück zum Zitat Sithithaworn P, Haswell-Elkins M (2003) Epidemiology of Opisthorchis viverrini. Acta Trop 88:187–194PubMedCrossRef Sithithaworn P, Haswell-Elkins M (2003) Epidemiology of Opisthorchis viverrini. Acta Trop 88:187–194PubMedCrossRef
4.
Zurück zum Zitat Thamavit W, Kongkanuntn R, Tiwawech D, Moore MA (1987) Level of Opisthorchis infestation and carcinogen dose-dependence of cholangiocarcinoma induction in Syrian golden hamsters. Virchows Arch B Cell Pathol Incl Mol Pathol 54:52–58PubMedCrossRef Thamavit W, Kongkanuntn R, Tiwawech D, Moore MA (1987) Level of Opisthorchis infestation and carcinogen dose-dependence of cholangiocarcinoma induction in Syrian golden hamsters. Virchows Arch B Cell Pathol Incl Mol Pathol 54:52–58PubMedCrossRef
5.
Zurück zum Zitat Thamavit W, Pairojkul C, Tiwawech D et al (1993) Promotion of cholangiocarcinogenesis in the hamster liver by bile duct ligation after dimethylnitrosamine initiation. Carcinogenesis 14:2415–2417PubMedCrossRef Thamavit W, Pairojkul C, Tiwawech D et al (1993) Promotion of cholangiocarcinogenesis in the hamster liver by bile duct ligation after dimethylnitrosamine initiation. Carcinogenesis 14:2415–2417PubMedCrossRef
6.
Zurück zum Zitat Thamavit W, Pairojkul C, Tiwawech D, Shirai T, Ito N (1994) Lack of promoting effect of proline on bile duct cancer development in dimethylnitrosamine-initiated hamster livers. Teratog Carcinog Mutagen 14:169–174PubMedCrossRef Thamavit W, Pairojkul C, Tiwawech D, Shirai T, Ito N (1994) Lack of promoting effect of proline on bile duct cancer development in dimethylnitrosamine-initiated hamster livers. Teratog Carcinog Mutagen 14:169–174PubMedCrossRef
7.
Zurück zum Zitat Li Y, Turck CM, Teumer JK, Stavnezer E (1986) Unique sequence, ski, in Sloan-Kettering avian retroviruses with properties of a new cell-derived oncogene. J Virol 57:1065–1072PubMed Li Y, Turck CM, Teumer JK, Stavnezer E (1986) Unique sequence, ski, in Sloan-Kettering avian retroviruses with properties of a new cell-derived oncogene. J Virol 57:1065–1072PubMed
8.
Zurück zum Zitat Colmenares C, Stavnezer E (1989) The ski oncogene induces muscle differentiation in quail embryo cells. Cell 59:293–303PubMedCrossRef Colmenares C, Stavnezer E (1989) The ski oncogene induces muscle differentiation in quail embryo cells. Cell 59:293–303PubMedCrossRef
9.
Zurück zum Zitat Fumagalli S, Doneda L, Nomura N, Larizza L (1993) Expression of the c-Ski proto-oncogene in human melanoma cell lines. Melanoma Res 3:23–27PubMedCrossRef Fumagalli S, Doneda L, Nomura N, Larizza L (1993) Expression of the c-Ski proto-oncogene in human melanoma cell lines. Melanoma Res 3:23–27PubMedCrossRef
10.
Zurück zum Zitat Pelzer T, Lyons GE, Kim S, Moreadith RW (1996) Cloning and characterization of the murine homolog of the sno proto-oncogene reveals a novel splice variant. Dev Dyn 205:114–125PubMedCrossRef Pelzer T, Lyons GE, Kim S, Moreadith RW (1996) Cloning and characterization of the murine homolog of the sno proto-oncogene reveals a novel splice variant. Dev Dyn 205:114–125PubMedCrossRef
11.
Zurück zum Zitat Atanasoski S, Notterpek L, Lee HY et al (2004) The protooncogene Ski controls Schwann cell proliferation and myelination. Neuron 43:499–511PubMedCrossRef Atanasoski S, Notterpek L, Lee HY et al (2004) The protooncogene Ski controls Schwann cell proliferation and myelination. Neuron 43:499–511PubMedCrossRef
12.
Zurück zum Zitat Reed JA, Bales E, Xu W, Okan NA, Bandyopadhyay D, Medrano EE (2001) Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling. Cancer Res 61:8074–8078PubMed Reed JA, Bales E, Xu W, Okan NA, Bandyopadhyay D, Medrano EE (2001) Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling. Cancer Res 61:8074–8078PubMed
13.
Zurück zum Zitat Reed JA, Lin Q, Chen D, Mian IS, Medrano EE (2005) SKI pathways inducing progression of human melanoma. Cancer Metastasis Rev 24:265–272PubMedCrossRef Reed JA, Lin Q, Chen D, Mian IS, Medrano EE (2005) SKI pathways inducing progression of human melanoma. Cancer Metastasis Rev 24:265–272PubMedCrossRef
14.
Zurück zum Zitat Markowitz S, Wang J, Myeroff L et al (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268:1336–1338PubMedCrossRef Markowitz S, Wang J, Myeroff L et al (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268:1336–1338PubMedCrossRef
15.
Zurück zum Zitat Miyaki M, Iijima T, Konishi M et al (1999) Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 18:3098–3103PubMedCrossRef Miyaki M, Iijima T, Konishi M et al (1999) Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 18:3098–3103PubMedCrossRef
16.
Zurück zum Zitat Namciu S, Lyons GE, Micales BK et al (1995) Enhanced expression of mouse c-Ski accompanies terminal skeletal muscle differentiation in vivo and in vitro. Dev Dyn 204:291–300PubMedCrossRef Namciu S, Lyons GE, Micales BK et al (1995) Enhanced expression of mouse c-Ski accompanies terminal skeletal muscle differentiation in vivo and in vitro. Dev Dyn 204:291–300PubMedCrossRef
17.
Zurück zum Zitat Zhang F, Lundin M, Ristimäki A et al (2003) Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-beta signaling, is a prognostic marker in estrogen receptor-positive breast carcinomas. Cancer Res 63:5005–5010PubMed Zhang F, Lundin M, Ristimäki A et al (2003) Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-beta signaling, is a prognostic marker in estrogen receptor-positive breast carcinomas. Cancer Res 63:5005–5010PubMed
18.
Zurück zum Zitat Fukuchi M, Nakajima M, Fukai Y et al (2004) Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma. Int J Cancer 108:818–824PubMedCrossRef Fukuchi M, Nakajima M, Fukai Y et al (2004) Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma. Int J Cancer 108:818–824PubMedCrossRef
19.
Zurück zum Zitat Ritter M, Kattmann D, Teichler S et al (2006) Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia. Leukemia 20:437–443PubMedCrossRef Ritter M, Kattmann D, Teichler S et al (2006) Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia. Leukemia 20:437–443PubMedCrossRef
20.
Zurück zum Zitat Bravou V, Antonacopoulou A, Papadaki H et al (2009) TGF-beta repressors SnoN and Ski are implicated in human colorectal carcinogenesis. Cell Oncol 31:41–51PubMed Bravou V, Antonacopoulou A, Papadaki H et al (2009) TGF-beta repressors SnoN and Ski are implicated in human colorectal carcinogenesis. Cell Oncol 31:41–51PubMed
21.
Zurück zum Zitat Shi Y, Massague J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685–700PubMedCrossRef Shi Y, Massague J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685–700PubMedCrossRef
23.
Zurück zum Zitat Boonmars T, Srisawangwong T, Srirach P et al (2007) Apoptosis-related gene expressions in hamsters re-infected with Opisthorchis viverrini and re-treated with praziquantel. Parasitol Res 102:57–62PubMedCrossRef Boonmars T, Srisawangwong T, Srirach P et al (2007) Apoptosis-related gene expressions in hamsters re-infected with Opisthorchis viverrini and re-treated with praziquantel. Parasitol Res 102:57–62PubMedCrossRef
24.
Zurück zum Zitat Luo K (2004) Ski and SnoN: negative regulators of TGF-beta signaling. Curr Opin Genet Dev 14:65–70PubMedCrossRef Luo K (2004) Ski and SnoN: negative regulators of TGF-beta signaling. Curr Opin Genet Dev 14:65–70PubMedCrossRef
25.
Zurück zum Zitat Akiyoshi S, Inoue H, Hanai J et al (1999) c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads. J Biol Chem 274:35269–35277PubMedCrossRef Akiyoshi S, Inoue H, Hanai J et al (1999) c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads. J Biol Chem 274:35269–35277PubMedCrossRef
26.
Zurück zum Zitat Prunier C, Pessah M, Ferrand N et al (2003) The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation. J Biol Chem 278:26249–26257PubMedCrossRef Prunier C, Pessah M, Ferrand N et al (2003) The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation. J Biol Chem 278:26249–26257PubMedCrossRef
27.
Zurück zum Zitat Suzuki H, Yagi K, Kondo M et al (2004) c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad- binding elements. Oncogene 23:5068–5076PubMedCrossRef Suzuki H, Yagi K, Kondo M et al (2004) c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad- binding elements. Oncogene 23:5068–5076PubMedCrossRef
28.
Zurück zum Zitat Zhang B, Halder SK, Zhang S, Datta PK (2009) Targeting transforming growth factor-beta signaling in liver metastasis of colon cancer. Cancer Lett 277:114–120PubMedCrossRef Zhang B, Halder SK, Zhang S, Datta PK (2009) Targeting transforming growth factor-beta signaling in liver metastasis of colon cancer. Cancer Lett 277:114–120PubMedCrossRef
29.
Zurück zum Zitat Patsenker E, Popov Y, Stickel F et al (2008) Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression. Gastroenterology 135:660–670PubMedCrossRef Patsenker E, Popov Y, Stickel F et al (2008) Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression. Gastroenterology 135:660–670PubMedCrossRef
30.
Zurück zum Zitat Dumont N, Arteaga CL (2000) Transforming growth factor-β and breast cancer: tumor promoting effects of transforming growth factor-β. Breast Cancer Res 2:125–132PubMedCrossRef Dumont N, Arteaga CL (2000) Transforming growth factor-β and breast cancer: tumor promoting effects of transforming growth factor-β. Breast Cancer Res 2:125–132PubMedCrossRef
31.
Zurück zum Zitat Milani S, Herbst H, Schuppan D, Stein H, Surrenti C (1991) Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol 139:1221–1229PubMed Milani S, Herbst H, Schuppan D, Stein H, Surrenti C (1991) Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol 139:1221–1229PubMed
32.
Zurück zum Zitat Levy L, Hill CS (2006) Alterations in components of the TGF-β superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev 17:41–58PubMedCrossRef Levy L, Hill CS (2006) Alterations in components of the TGF-β superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev 17:41–58PubMedCrossRef
33.
Zurück zum Zitat Dranoff G (2004) Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 4:11–22PubMedCrossRef Dranoff G (2004) Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 4:11–22PubMedCrossRef
34.
Zurück zum Zitat Jakowlew SB (2006) Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev 25:435–457PubMedCrossRef Jakowlew SB (2006) Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev 25:435–457PubMedCrossRef
35.
Zurück zum Zitat Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Massagué J (1990) Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175–185PubMedCrossRef Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Massagué J (1990) Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175–185PubMedCrossRef
36.
Zurück zum Zitat Hannon GJ, Beach D (1994) p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371:257–261PubMedCrossRef Hannon GJ, Beach D (1994) p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371:257–261PubMedCrossRef
37.
Zurück zum Zitat Iavarone A, Massague J (1999) E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle arrest. Mol Cell Biol 19:916–940PubMed Iavarone A, Massague J (1999) E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle arrest. Mol Cell Biol 19:916–940PubMed
38.
Zurück zum Zitat Jang CW, Chen CH, Chen CC et al (2002) TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase. Nat Cell Biol 4:51–58PubMedCrossRef Jang CW, Chen CH, Chen CC et al (2002) TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase. Nat Cell Biol 4:51–58PubMedCrossRef
39.
Zurück zum Zitat Kim BG, Li C, Qiao W et al (2006) Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 441:1015–1019PubMedCrossRef Kim BG, Li C, Qiao W et al (2006) Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 441:1015–1019PubMedCrossRef
40.
Zurück zum Zitat Kang YK, Kim WH, Jang JJ (2002) Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma. Hum Pathol 33:877–883PubMedCrossRef Kang YK, Kim WH, Jang JJ (2002) Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma. Hum Pathol 33:877–883PubMedCrossRef
41.
Zurück zum Zitat Liu Y, Wang LF, Zou HF, Song XY, Xu HF, Lin P, Zheng HH, Yu XG (2006) Expression and location of Smad2, 4 mRNAs during and after liver fibrogenesis of rats. World J Gastroenterol 14;12(10):1577–1582 Liu Y, Wang LF, Zou HF, Song XY, Xu HF, Lin P, Zheng HH, Yu XG (2006) Expression and location of Smad2, 4 mRNAs during and after liver fibrogenesis of rats. World J Gastroenterol 14;12(10):1577–1582
Metadaten
Titel
Involvement of c-Ski Oncoprotein in Carcinogenesis of Cholangiocacinoma Induced by Opisthorchis viverrini and N-nitrosodimethylamine
verfasst von
Thidarut Boonmars
Zhiliang Wu
Sirintip Boonjaruspinyo
Anucha Puapairoj
Butsara Kaewsamut
Isao Nagano
Somchai Pinlaor
Puangrat Yongvanit
Orasa Wonkchalee
Amornrat Juasook
Pakkayanee Sudsarn
Tuanchai Srisawangwong
Publikationsdatum
01.06.2011
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 2/2011
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-010-9300-8

Weitere Artikel der Ausgabe 2/2011

Pathology & Oncology Research 2/2011 Zur Ausgabe

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.